Related Experiment Video

Updated: Aug 19, 2026

Isolation of Lung Retinoid-Containing Cells by Cell Sorting
07:47

Isolation of Lung Retinoid-Containing Cells by Cell Sorting

Published on: April 11, 2025

Nonclassical retinoids and lung carcinogenesis

Konstantin H Dragnev1, W Jeffrey Petty, Yan Ma

  • 1Hematology/Oncology Section, Department of Medicine, Dartmouth-Hitchcock Medical Center, Hanover, NH 03756, USA. dragnev@dartmouth.edu

Clinical Lung Cancer
|February 8, 2005
PubMed

Insights

Rexinoids, vitamin A derivatives, show promise in cancer therapy by halting cell growth and inducing cell death. Clinical trials are evaluating their effectiveness in treating non-small-cell lung cancer (NSCLC).

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Retinoids, vitamin A derivatives, are known for their anticancer properties, including antiproliferative and proapoptotic effects.
  • Retinoids function by activating nuclear retinoid receptors, influencing gene expression and cellular processes.
  • Rexinoids specifically target the nuclear retinoid X receptors (RXRs), playing a role in cancer treatment strategies.

Purpose of the Study:

  • To investigate the mechanisms of rexinoid action in cancer, particularly in human bronchial epithelial cells.
  • To review the clinical evidence supporting the use of rexinoids in non-small-cell lung cancer (NSCLC) therapy.
  • To explore the potential of rexinoids in combination regimens for enhanced cancer treatment.

Main Methods:

  • Analysis of rexinoid-induced G1 cell cycle arrest and growth suppression in bronchial epithelial cells.
  • Investigation of proteasome-dependent degradation pathways involved in rexinoid action.
  • Review of clinical trial data on rexinoid monotherapy and combination therapy in NSCLC patients.

Main Results:

  • Rexinoid treatment triggered G1 cell cycle arrest and growth suppression in human bronchial epithelial cells.
  • This effect was associated with decreased expression of G1 cyclins via proteasome-dependent degradation.
  • Clinical studies indicated prolonged survival in subsets of NSCLC patients treated with rexinoids.

Conclusions:

  • Rexinoids demonstrate significant potential as anticancer agents, particularly in NSCLC.
  • Their ability to activate RXR makes them valuable candidates for combination therapies with other targeted agents or chemotherapy.
  • Further randomized phase III trials are crucial to establish the definitive role of rexinoids in lung cancer therapy and chemoprevention.

More Related Videos

Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography05:03

Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography

Published on: December 27, 2024

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes: